Edition:
Deutschland

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

1,906JPY
08:00 Uhr
Change (% chg)

¥45 (+2.42%)
Prev Close
¥1,861
Open
¥1,872
Day's High
¥1,906
Day's Low
¥1,852
Volume
858,500
Avg. Vol
952,226
52-wk High
¥4,135
52-wk Low
¥1,661

About

Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Company operates in four segments. The Japan segment manufactures and sells medical drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated... (more)

Buy/Sell

Sell Hold Buy
3.44 Mean rating from 9 analysts

Overall

Beta: 0.48
Market Cap(Mil.): ¥765,957.81
Shares Outstanding(Mil.): 397.90
Dividend: 14.00
Yield (%): 1.45

Sumitomo Dainippon Pharma investing $3 billion in Swiss Roivant in overseas push

TOKYO Japan's Sumitomo Dainippon Pharma Co will pay $3 billion for a 10% stake in Swiss drugmaker Roivant Sciences Ltd and interests in five of its biopharmaceutical businesses, the two companies said on Friday.

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units

Sumitomo Dainippon Pharma to invest $3 bln in Swiss Roivant

TOKYO, Sept 6 Japan's Sumitomo Dainippon Pharma Co will pay $3 billion for a 10% stake in Swiss drugmaker Roivant Sciences Ltd and interests in five of its biopharmaceutical businesses, the two companies said on Friday.

Nikkei ends flat despite strong chip makers

TOKYO, March 22 Japan's Nikkei ended little changed on Friday as chip-related stocks offset weakness in financial stocks and drugmakers, which tumbled after Eisai said it will end its Alzheimer drug trials.

Nikkei falls as financials drag; Eisai indicated to dive

TOKYO, March 22 Japan's Nikkei fell in choppy trade on Friday as financial stocks languished, reflecting more cautious U.S. monetary policy, while the drug sector tumbled after Eisai and Biogen said they will end their Alzheimer's drug trials.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.46%
Rohstoffe +0.04%
Industrie -0.13%
Konjunktur abhängige Waren & Dienstleistungen +0.17%
Konjunktur unabhängige Waren & Dienstleistungen -0.07%
Finanzindustrie +0.10%
Pharma +0.05%
Technologie -0.18%
Telekommunikation +0.13%

Nachrichten aus der Wirtschaft

Photo

Börsianer heben Konjunkturaussichten an - "Keine Entwarnung"

Berlin Die Konjunkturhilfen der Europäischen Zentralbank (EZB) und Hoffnungen auf einen geordneten Brexit lassen Börsianer die deutschen Konjunkturaussichten nicht mehr ganz so düster einschätzen.